• Je něco špatně v tomto záznamu ?

RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia

AR. Poetsch, DB. Lipka, T. Witte, R. Claus, P. Nöllke, M. Zucknick, C. Olk-Batz, S. Fluhr, M. Dworzak, B. De Moerloose, J. Starý, M. Zecca, H. Hasle, M. Schmugge, MM. van den Heuvel-Eibrink, F. Locatelli, CM. Niemeyer, C. Flotho, C. Plass,

. 2014 ; 9 (9) : 1252-60.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023108

Aberrant DNA methylation at specific genetic loci is a key molecular feature of juvenile myelomonocytic leukemia (JMML) with poor prognosis. Using quantitative high-resolution mass spectrometry, we identified RASA4 isoform 2, which maps to chromosome 7 and encodes a member of the GAP1 family of GTPase-activating proteins for small G proteins, as a recurrent target of isoform-specific DNA hypermethylation in JMML (51% of 125 patients analyzed). RASA4 isoform 2 promoter methylation correlated with clinical parameters predicting poor prognosis (older age, elevated fetal hemoglobin), with higher risk of relapse after hematopoietic stem cell transplantation, and with PTPN11 mutation. The level of isoform 2 methylation increased in relapsed cases after transplantation. Interestingly, most JMML cases with monosomy 7 exhibited hypermethylation on the remaining RASA4 allele. The results corroborate the significance of epigenetic modifications in the phenotype of aggressive JMML.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023108
003      
CZ-PrNML
005      
20230331095215.0
007      
ta
008      
150709s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.4161/epi.29941 $2 doi
035    __
$a (PubMed)25147919
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Poetsch, Anna R $u Division of Epigenomics and Cancer Risk Factors (C010); German Cancer Research Center; Heidelberg, Germany.
245    10
$a RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia / $c AR. Poetsch, DB. Lipka, T. Witte, R. Claus, P. Nöllke, M. Zucknick, C. Olk-Batz, S. Fluhr, M. Dworzak, B. De Moerloose, J. Starý, M. Zecca, H. Hasle, M. Schmugge, MM. van den Heuvel-Eibrink, F. Locatelli, CM. Niemeyer, C. Flotho, C. Plass,
520    9_
$a Aberrant DNA methylation at specific genetic loci is a key molecular feature of juvenile myelomonocytic leukemia (JMML) with poor prognosis. Using quantitative high-resolution mass spectrometry, we identified RASA4 isoform 2, which maps to chromosome 7 and encodes a member of the GAP1 family of GTPase-activating proteins for small G proteins, as a recurrent target of isoform-specific DNA hypermethylation in JMML (51% of 125 patients analyzed). RASA4 isoform 2 promoter methylation correlated with clinical parameters predicting poor prognosis (older age, elevated fetal hemoglobin), with higher risk of relapse after hematopoietic stem cell transplantation, and with PTPN11 mutation. The level of isoform 2 methylation increased in relapsed cases after transplantation. Interestingly, most JMML cases with monosomy 7 exhibited hypermethylation on the remaining RASA4 allele. The results corroborate the significance of epigenetic modifications in the phenotype of aggressive JMML.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a lidské chromozomy, pár 7 $7 D002897
650    _2
$a CpG ostrůvky $7 D018899
650    12
$a metylace DNA $7 D019175
650    12
$a chemorezistence $7 D019008
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a umlčování genů $7 D020868
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a juvenilní myelomonocytární leukemie $x diagnóza $x metabolismus $x patologie $7 D054429
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a monozomie $7 D009006
650    _2
$a mutace $7 D009154
650    _2
$a prognóza $7 D011379
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a protein - isoformy $x genetika $x metabolismus $7 D020033
650    _2
$a tyrosinfosfatasa nereceptorového typu 11 $x genetika $x metabolismus $7 D054592
650    _2
$a proteiny aktivující GTPasu ras $x genetika $x metabolismus $7 D020703
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lipka, Daniel B $u Division of Epigenomics and Cancer Risk Factors (C010); German Cancer Research Center; Heidelberg, Germany.
700    1_
$a Witte, Tania $u Division of Epigenomics and Cancer Risk Factors (C010); German Cancer Research Center; Heidelberg, Germany.
700    1_
$a Claus, Rainer $u Division of Epigenomics and Cancer Risk Factors (C010); German Cancer Research Center; Heidelberg, Germany.
700    1_
$a Nöllke, Peter $u Division of Pediatric Hematology-Oncology; University Medical Center; Freiburg, Germany.
700    1_
$a Zucknick, Manuela $u Division of Biostatistics; German Cancer Research Center; Heidelberg, Germany.
700    1_
$a Olk-Batz, Christiane $u Division of Pediatric Hematology-Oncology; University Medical Center; Freiburg, Germany.
700    1_
$a Fluhr, Silvia $u Division of Pediatric Hematology-Oncology; University Medical Center; Freiburg, Germany.
700    1_
$a Dworzak, Michael $u St. Anna Children's Hospital and Children's Cancer Research Institute; Department of Pediatrics; Medical University of Vienna; Vienna, Austria.
700    1_
$a De Moerloose, Barbara $u Dept. of Pediatric Hematology-Oncology; Ghent University Hospital; Ghent, Belgium.
700    1_
$a Starý, Jan $u Dept. of Pediatric Hematology and Oncology; 2nd Faculty of Medicine; Charles University and University Hospital Motol, Praha; Czech Pediatric Hematology Working Group (CPH); Prague, Czech Republic.
700    1_
$a Zecca, Marco $u Pediatric Hematology-Oncology; Fondazione IRCCS;Policlinico San Matteo; Pavia, Italy.
700    1_
$a Hasle, Henrik $u Department of Pediatrics; Aarhus University Hospital Skejby; Aarhus, Denmark.
700    1_
$a Schmugge, Markus $u Division of Hematology; University Children's Hospital; Zurich, Switzerland.
700    1_
$a van den Heuvel-Eibrink, Marry M $u Department of Pediatric Oncology-Hematology; Erasmus Medical Center; Rotterdam, The Netherlands; Dutch Children's Oncology Group; The Hague, Netherlands.
700    1_
$a Locatelli, Franco $u Department of Pediatric Hematology-Oncology; IRCCS Ospedale Bambino Gesu; Rome, Italy; University of Pavia; Pavia, Italy.
700    1_
$a Niemeyer, Charlotte M $u The German Cancer Consortium; Heidelberg, Germany; Division of Pediatric Hematology-Oncology; University Medical Center; Freiburg, Germany.
700    1_
$a Flotho, Christian $u The German Cancer Consortium; Heidelberg, Germany; Division of Pediatric Hematology-Oncology; University Medical Center; Freiburg, Germany.
700    1_
$a Plass, Christoph $u Division of Epigenomics and Cancer Risk Factors (C010); German Cancer Research Center; Heidelberg, Germany; The German Cancer Consortium; Heidelberg, Germany.
773    0_
$w MED00180218 $t Epigenetics. $x 1559-2308 $g Roč. 9, č. 9 (2014), s. 1252-60
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25147919 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20230331095210 $b ABA008
999    __
$a ok $b bmc $g 1083446 $s 906101
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 9 $c 9 $d 1252-60 $i 1559-2308 $m Epigenetics. $n Epigenetics $x MED00180218
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Možnosti archivace